News
Bayer and Vividion Therapeutics to present latest research on their advancing oncology portfolio at AACR 2025 annual meeting: Berlin, Germany Wednesday, April 23, 2025, 10:00 Hrs ...
BANGKOK — A new report published on Feb. 18 detailed widespread discrepancies in data provided from Southeast Asia’s ...
Roche projected that its $50 billion manufacturing investment, to include R&D operations, will generate 1,000 jobs at the ...
Investing.com -- The U.S. Department of Health and Human Services (HHS) and the U.S. Food and Drug Administration (FDA) announced new measures today to eliminate all petroleum-based synthetic dyes ...
A team of scientists has uncovered the mechanism of cellular uptake for large and polar drugs and devised a novel strategy to ...
Roche will invest $50 billion in U.S. manufacturing, including a new plant in Indiana. The Trump administration is considering tariffs on drugmakers.
AstraZeneca has rejoined the main U.S. drug lobby group, roughly two years after leaving it, the Pharmaceutical Research and ...
Trump proposed a change to Medicare price talks that has long been sought after by the pharmaceutical industry.
GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire ...
The big pharma joined several of its peers in committing to invest billions of dollars in new and expanded manufacturing ...
Rapid breast cancer research offers new hope, as discussed by Joyce O’Shaughnessy, MD, regarding HR+/HER2– and HER2+ disease.
The FDA is shifting towards a more human-relevant approach to drug testing, encouraging the use of New Approach Methodologies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results